1. Home
  2. WLFC vs MDXG Comparison

WLFC vs MDXG Comparison

Compare WLFC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLFC
  • MDXG
  • Stock Information
  • Founded
  • WLFC 1985
  • MDXG 2006
  • Country
  • WLFC United States
  • MDXG United States
  • Employees
  • WLFC N/A
  • MDXG N/A
  • Industry
  • WLFC Industrial Specialties
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLFC Consumer Discretionary
  • MDXG Health Care
  • Exchange
  • WLFC Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • WLFC 1.0B
  • MDXG 1.0B
  • IPO Year
  • WLFC 1996
  • MDXG N/A
  • Fundamental
  • Price
  • WLFC $133.87
  • MDXG $6.95
  • Analyst Decision
  • WLFC
  • MDXG Buy
  • Analyst Count
  • WLFC 0
  • MDXG 1
  • Target Price
  • WLFC N/A
  • MDXG $12.00
  • AVG Volume (30 Days)
  • WLFC 63.2K
  • MDXG 699.9K
  • Earning Date
  • WLFC 11-03-2025
  • MDXG 10-29-2025
  • Dividend Yield
  • WLFC 0.74%
  • MDXG N/A
  • EPS Growth
  • WLFC 30.03
  • MDXG N/A
  • EPS
  • WLFC 16.84
  • MDXG 0.21
  • Revenue
  • WLFC $637,163,000.00
  • MDXG $363,774,000.00
  • Revenue This Year
  • WLFC $16.17
  • MDXG $12.68
  • Revenue Next Year
  • WLFC $4.88
  • MDXG $8.18
  • P/E Ratio
  • WLFC $8.07
  • MDXG $33.71
  • Revenue Growth
  • WLFC 32.40
  • MDXG 6.85
  • 52 Week Low
  • WLFC $124.90
  • MDXG $5.47
  • 52 Week High
  • WLFC $235.43
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • WLFC 34.54
  • MDXG 47.09
  • Support Level
  • WLFC $134.39
  • MDXG $6.62
  • Resistance Level
  • WLFC $137.85
  • MDXG $7.35
  • Average True Range (ATR)
  • WLFC 3.67
  • MDXG 0.23
  • MACD
  • WLFC -0.74
  • MDXG 0.00
  • Stochastic Oscillator
  • WLFC 8.06
  • MDXG 45.89

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: